Pnc Financial Services Group, Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 210 shares of TARS stock, worth $10,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210
Previous 180
16.67%
Holding current value
$10,869
Previous $5,000
120.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
178Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$177 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$169 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$129 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$126 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$117 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.38B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...